State Insurance Mandates and the Workforce for Children With Autism.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
10 2020
Historique:
accepted: 04 06 2020
pubmed: 10 9 2020
medline: 21 10 2020
entrez: 9 9 2020
Statut: ppublish

Résumé

State mandates have required insurance companies to provide coverage for autism-related child health care services; however, it has not been determined if insurance mandates have improved the supply of child health care providers. We investigate the effect of state insurance mandates on the supply of child psychiatrists, pediatricians, and board-certified behavioral analysts (BCBAs). We used data from the National Conference of State Legislatures and Health Resources and Services Administration's Area Health Resource Files to examine child psychiatrists, pediatricians, and BCBAs in all 50 states from 2003 to 2017. Fixed-effects regression models compared change in workforce density before versus one year after mandate implementation and the effect of mandate generosity across 44 US states implementing mandates between 2003 and 2017. From 2003 to 2017, child psychiatrists increased from 7.40 to 10.03 per 100 000 children, pediatricians from 62.35 to 68.86, and BCBAs from 1.34 to 29.88. Mandate introduction was associated with an additional increase of 0.77 BCBAs per 100 000 children (95% confidence interval [CI]: 0.18 to 1.42) one year after mandate enactment. Mandate introduction was also associated with a more modest increase among child psychiatrists (95% CI: 0.10 to 0.91) and was not associated with the prevalence of pediatricians (95% CI: -0.76 to 1.13). We also found evidence that more generous mandate benefits were associated with larger effects on workforce supply. State insurance mandates were associated with an ∼16% increase in BCBAs from 2003 to 2017, but the association with child psychiatrists was smaller and nonsignificant among pediatricians. In these findings, it is suggested that policies are needed that specifically address workforce constraints in the provision of services for children with autism spectrum disorder.

Sections du résumé

BACKGROUND
State mandates have required insurance companies to provide coverage for autism-related child health care services; however, it has not been determined if insurance mandates have improved the supply of child health care providers. We investigate the effect of state insurance mandates on the supply of child psychiatrists, pediatricians, and board-certified behavioral analysts (BCBAs).
METHODS
We used data from the National Conference of State Legislatures and Health Resources and Services Administration's Area Health Resource Files to examine child psychiatrists, pediatricians, and BCBAs in all 50 states from 2003 to 2017. Fixed-effects regression models compared change in workforce density before versus one year after mandate implementation and the effect of mandate generosity across 44 US states implementing mandates between 2003 and 2017.
RESULTS
From 2003 to 2017, child psychiatrists increased from 7.40 to 10.03 per 100 000 children, pediatricians from 62.35 to 68.86, and BCBAs from 1.34 to 29.88. Mandate introduction was associated with an additional increase of 0.77 BCBAs per 100 000 children (95% confidence interval [CI]: 0.18 to 1.42) one year after mandate enactment. Mandate introduction was also associated with a more modest increase among child psychiatrists (95% CI: 0.10 to 0.91) and was not associated with the prevalence of pediatricians (95% CI: -0.76 to 1.13). We also found evidence that more generous mandate benefits were associated with larger effects on workforce supply.
CONCLUSIONS
State insurance mandates were associated with an ∼16% increase in BCBAs from 2003 to 2017, but the association with child psychiatrists was smaller and nonsignificant among pediatricians. In these findings, it is suggested that policies are needed that specifically address workforce constraints in the provision of services for children with autism spectrum disorder.

Identifiants

pubmed: 32900876
pii: peds.2020-0836
doi: 10.1542/peds.2020-0836
pmc: PMC7546088
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH112760
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Références

JAMA Intern Med. 2019 Jun 1;179(6):805-811
pubmed: 31058922
JAMA Psychiatry. 2017 May 1;74(5):476-484
pubmed: 28384733
Health Aff (Millwood). 2020 Jun;39(6):968-974
pubmed: 32479238
Pediatrics. 2013 Aug;132(2):390-7
pubmed: 23897908
Pediatrics. 2018 Mar;141(3):
pubmed: 29453235
JAMA Psychiatry. 2014 Feb;71(2):176-81
pubmed: 24337499
JAMA Psychiatry. 2018 May 1;75(5):514-523
pubmed: 29590280
Pediatrics. 2019 Jun;143(6):
pubmed: 31092588
Annu Rev Psychol. 1995;46:433-65
pubmed: 7872734
Health Aff (Millwood). 2017 Oct 1;36(10):1754-1761
pubmed: 28971920
JAMA Pediatr. 2019 Apr 1;173(4):389-391
pubmed: 30742204
PLoS One. 2019 May 24;14(5):e0217064
pubmed: 31125366
JAMA Pediatr. 2014 Aug;168(8):721-8
pubmed: 24911948
J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):113-139
pubmed: 31150751
Autism. 2014 Oct;18(7):803-14
pubmed: 24789870
J Dev Behav Pediatr. 2016 Nov/Dec;37(9):687-693
pubmed: 27801720
Int J Health Serv. 2017 Oct;47(4):621-635
pubmed: 28474997
Behav Anal Pract. 2016 Mar 28;9(3):243-52
pubmed: 27622129
J Autism Dev Disord. 2010 Mar;40(3):317-24
pubmed: 19768528
Autism. 2019 Jan;23(1):167-174
pubmed: 29126371
Med Care. 2018 Mar;56(3):228-232
pubmed: 29287035
Health Aff (Millwood). 2018 Jan;37(1):22-29
pubmed: 29309229
Pediatrics. 2019 Dec;144(6):
pubmed: 31685696
J Pediatr. 2019 Mar;206:256-267.e3
pubmed: 30322701
J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9
pubmed: 18645422
Pediatrics. 2012 Apr;129(4):617-23
pubmed: 22430453
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730

Auteurs

Ryan K McBain (RK)

RAND Corporation, Boston, Massachusetts; rmcbain@rand.org.

Jonathan H Cantor (JH)

RAND Corporation, Santa Monica, California.

Aaron Kofner (A)

RAND Corporation, Arlington, Virginia.

Bradley D Stein (BD)

RAND Corporation, Pittsburgh, Pennsylvania; and.

Hao Yu (H)

Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Harvard University, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH